Interim Management Statement

Keystone Investment Trust plc Interim Management Statement for thethree months ended 30 June 2012 Material Events No material events occurred in the period. Dividends In the period, an interim dividend of 18p per ordinary share was paid on 29 June 2012 to shareholders on the register on 1 June 2012. Performance - Total Return 3 Months 1 Year 3 Years 5 Years Share Price -0.1% 0.6% 47.8% 29.3% Net Asset Value 0.3% 2.4% 53.5% 15.7% FTSE All-Share Index -2.6% -3.1% 47.4% 2.0% Source: Thomson Reuters Datastream Share Price and Discount At For the Three Months Ended 30 June 2012 30-Jun-12 High Low Average Share Price (pence) 1205.00 1245.00 1160.00 1205.81 Discount (debt at par) (7.3%) Discount (debt at fair (3.9%) value) Source: Thomson Reuters Datastream Assets and Gearing 30-Jun-12 Total Gross Assets (£m) 207.1 of which cash and Certificates of Deposit(£ 14.0 m) Borrowings (£m) 33.4 Cum Income Net Asset Value (pence) 1300.0 Gross Gearing 19.2% Net Gearing 10.8% `Gross Gearing' reflects the amount of gross borrowings in use by a company and takes no accounts of any cash balances. It is based on gross borrowings as a percentage of shareholder funds. `Net Gearing' reflects the amount of net borrowings invested, i.e borrowings less cash and bond holdings. It is based on net borrowings as a percentage of shareholders' funds. The Company's structured debt is provided by 250,000 5% cumulative preference shares of £1 each and the following debentures totalling £32 million: - £7,000,000 7.75% debenture stock 2020 - £25,000,000 6.5% debenture stock 2023 Sector Breakdown of Portfolio (excluding Cash and Certificates of Deposit) 30-Jun-12 Consumer Goods 19.6% Healthcare 18.6% Financials 15.7% Industrials 13.7% Telecommunications 13.0% Consumer Services 7.6% Utilities 7.4% Oil & Gas 3.9% Fixed Interest 0.3% Basic Materials 0.2% 100.0% Top Ten Holdings Investments % of Portfolio Reynolds American - US Common Stock 5.5% BT 5.4% British American Tobacco 5.3% Imperial Tobacco 5.1% Vodafone 4.4% GlaxoSmithKline 4.2% BG 3.9% AstraZeneca 3.8% Roche - Swiss Common Stock 3.5% Reckitt Benckiser 3.1% All ordinary shares unless otherwise stated Changes to Share Capital Ordinary Shares of 50p each Issued As at 31 Mar 2012 13,368,799 Shares bought back 0 Shares issued 0 As at 30 Jun 2012 13,368,799 The Company has authority to buy back shares for cancellation and to issue new shares (disapplying pre-emption rights), in each case within specified limits. The Company expects to renew these authorities each year. Administration The Company's Ordinary shares are listed on the London Stock Exchange and the price is published in the Times and the Financial Times under `Investment Companies' and in the Daily Telegraph under `Investment Trusts'. The Company's net asset value is calculated on a daily basis and can be viewed on the London Stock Exchange website at www.londonstockexchange.com Further information can be obtained from Invesco Perpetual as follows: Free Investor Helpline: 0800 085 8677 Internet address: www.invescoperpetual.co.uk/investmenttrusts The information provided in this statement should not be considered as a financial promotion. Interim management statements are expected to be published in January and July each year. Invesco Asset Management Limited For and on behalf of The Board of Keystone Investment Trust plc 26 July 2012
UK 100

Latest directors dealings